Editas Medicine (EDIT) Revenue Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) Revenue Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12,265.57% |
| Jun 30, 2025 | 597.47% |
| Mar 31, 2025 | 310.40% |
| Dec 31, 2024 | -49.03% |
| Sep 30, 2024 | -98.86% |
| Jun 30, 2024 | -82.23% |
| Mar 31, 2024 | -88.48% |
| Dec 31, 2023 | 818.74% |
| Sep 30, 2023 | 12,604.76% |
| Jun 30, 2023 | -54.62% |
| Mar 31, 2023 | 45.49% |
| Dec 31, 2022 | -47.58% |
| Sep 30, 2022 | -99.32% |
| Jun 30, 2022 | 1,578.63% |
| Mar 31, 2022 | 4.19% |
| Dec 31, 2021 | 9.20% |
| Sep 30, 2021 | -90.14% |
| Jun 30, 2021 | -96.47% |
| Mar 31, 2021 | 13.56% |
| Dec 31, 2020 | -7.04% |